4//SEC Filing
Cruse Michael 4
Accession 0001209191-21-053520
CIK 0001637715other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:51 PM ET
Size
5.0 KB
Accession
0001209191-21-053520
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Purchase
Common Stock
2021-08-25$7.45/sh+2,500$18,616→ 2,500 total
Footnotes (1)
- [F1]The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001854179
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:51 PM ET
- Size
- 5.0 KB